Acquisition of Own Shares
Lakefront Biotherapeutics repurchased 107,804 shares between October 12 and October 16, 2026, spending €2,854,365.69 at an average price of €26.48. With these purchases, the buyback program announced on June 9, 2026 has been fully completed, and the company now holds 1,985,157 of its own ordinary shares in treasury.
Key figures
- Shares held treasury
- 1985157
- Average price paid eur
- 26.48
- Shares repurchased week
- 107804
- Repurchase program status
- fully completed
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.